INTRODUCTION
Many patients undergoing topical retinoid therapy experience "retinoid dermatitis", a retinoid-specific irritant contact dermatitis, characterized by erythema, scaling, dryness, burning sensation, and pruritus 1 . Although clinical and histological alterations induced by topical retinoids are similar to those of nonspecific irritant-contact dermatitis, retinoid dermatitis is now accepted as distinct from nonspecific irritant-contact dermatitis in that the former is at least, in part, mediated through receptor-mediated cell signaling 2, 3 . Among the various retinoid-induced cutaneous changes, epidermal hyperproliferation and resultant scaling have been demonstrated to be mediated by retinoic acid receptor (RAR) signaling based on the finding that topical tretinoin failed to induce a hyperplasia and desquamation response in the epidermis of genetically engineered mice with a functional deficiency of RAR 4 .
However, it is still not clear how the interaction between retinoids and their receptors leads to retinoid dermatitis. Scaling and increased skin fragility are well-known adverse effects of retinoid therapy. Some previous studies have shown that scaling seems to be more prominent in retinoid-treated skin, compared to skin exposed to other irritants 5, 6 . Topically applied 0.05% or 0.1% all-trans retinoic acid (RA) appeared to cause more intense scaling than another irritant, sodium lauryl sulphate, in a 24-hour occlusive patch test 5 . Topical glycolic acid, another irritant, has also been shown to induce less scaling when compared with RA 7 . Scaling results from abnormal desquamation. The desquamation of stratum corneum (SC) is an active process of corneocyte shedding from the outer skin surface as a result of proteolytic degradation of corneodesmosomes, which are specialized structural proteins forming links or welds between adjacent corneocytes in the SC layer 8 . Three proteins have been described as components of the extracellular part of corneodesmosomes: the two desmosomal cadherins, desmoglein (DSG) 1 and desmocollin (DSC) 1 that associate in a calcium-dependent manner 9 , and corneodesmosin (CDSN), a characteristic adhesive glycoprotein secreted by the keratinocytes of granular layers and then incorporated into the desmosomes 10 . Degradation of corneodesmosomes is an important process during desquamation and is facilitated in a pH-dependent manner by the action of specific serine proteases in the epidermis, such as the human tissue kallikrein 5 (KLK5) and kallikrein 7 (KLK7) 11, 12 . Corneodesmosomal proteins that have been reported to be degraded during desquamation include DSG1, DSC1, plakoglobin, and CDSN 13, 14 .
A recent study demonstrated that the enzymatic degradation of corneodesmosomes weakened the strong interaction between corneocytes in the SC microstructure, making the tissue more susceptible to delamination fracture 15 . The pronounced scaling and peeling observed in retinoid dermatitis may be the indirect consequence of retinoid-induced epidermal proliferation and increased SC turnover, but RA could directly regulate the expression of corneodesmosomal components and thereby alter the desquamation process. To investigate this issue, we examined the ultrastructure of corneodesmosomes in the skin of hairless mice treated with a topical retinol application and compared the retinol-treated epidermis with vehicle-treated epidermis. In addition, to confirm whether the effects of RA on the structural alteration of corneodesmosomes were due to the ability of RA to directly regulate the expression of corneodesmosomal proteins, the effects of RA on the mRNA and protein levels of DSG1, DSC1, and CDSN (three major components of corneodesmosomes) were evaluated in cultured keratinocytes. We also measured mRNA expression levels of KLK5 and KLK7 to rule out the possibility that these two serine proteases could affect expression levels of corneodesmosomal proteins. Our results suggest that the downregulation of DSG1 and DSC1 without activation of KLKs by RA may be associated with abnormal desquamation observed in retinoid dermatitis.
MATERIALS AND METHODS

Animal experiments
Sixteen 6-week-old, female, hairless mice were used in this study. All animals were caged under controlled conditions (temperature: 23±3 o C and humidity: 50±10%).
Throughout the experiment, the mice were fed on standard mouse pellets and water ad libtum. A total of 2% all-trans-retinol (Sigma-Aldrich, St. Louis, MO, USA) in ethanol was applied to the left dorsal skin region, and ethanol alone as a vehicle was applied to the right dorsal skin region. Each solution was applied as a volume of 20 μl once a day for 5 consecutive days.
Electron microscopy
Samples for electron microscopy were obtained 24 hours after the last application, incubated in a fixative containing 2% glutaraldehyde, 2% formaldehyde, 90 mM potassium oxalate and 1.4% sucrose overnight prior to post-fixation. After post-fixation, all samples were dehydrated serially in an ascending alcohol series and embedded in 100% Polybed resin. Sections were viewed and photographed with an electron microscope (H-500, Hitachi, Japan).
Retinoic acid treatment in cultured keratinocytes
Human keratinocytes were isolated from normal human foreskin. The keratinocytes were seeded and maintained in 0.06 mM Ca 2+ keratinocyte growth medium (Cambrex, Walkersville, MD, USA) containing epidermal growth factor (100 ng/ml), bovine pituitary extract (70μg/ml), hydrocortisone (0.5μg/ml), and insulin (5μg/ml) in an incubator at 37 o C and 5% CO2. ). When keratinocytes covered more than 80% of the dish area, 10 −6 M and 10
M all-trans-retinoic acid (RA, Sigma-Aldrich) was added to the culture media, and the cells were cultured for 24 hours.
Western blot analysis
Keratinocytes were lysed in a 500μl lysis buffer containing 1.5% SDS and 0.0625 mol/L Tris-HCl buffer at a pH of 6.8, supplemented with 5% β-mercaptoethanol, 2 mM/L phenylmethylsulphonyl fluoride (PMSF; Sigma), and 2 mM/L EDTA. The cells were gathered by cell scraper and homogenized on ice. The mixture was boiled for 4 minutes and centrifuged to obtain a supernatant. The amount of protein was then quantified with a Bio-Rad Protein Assay Kit (Bio-Rad, Hercules, CA, USA) using the Bradford method. The protein extracts were loaded in 50μg-per-lane aliquots and separated with a NuPAGE gel (3-8% Novex Tris-Acetate Gel). After electrophoresis, proteins were transferred to a PVDF membrane (Millipore, Bedford, MA, USA). Membranes were incubated with antibodies for DSG1 and DSC1 (Progen, Heidelberg, Germany), KLK5, KLK7 (Santa Cruz, CA, USA) and β-actin (Sigma) at 4 o C. After overnight incubation, membranes were washed in Tris-buffered saline plus 0.1% Tween-20. Peroxidase-conjugated anti-mouse IgG (DAKO, Glostrup, Denmark) for DSG1, DSC1, or β-actin and anti-rabbit IgG (Invitrogen, Carlsbad, CA, USA) for KLK5 and KLK7 were used as secondary antibodies. Detection was carried out using an enhanced chemiluminescence detection kit (Amersham, Little Chalfont, UK). For quantitative comparison, the blotting intensity of each band on X-ray film (Kodak, Rochester, NY, USA) was assessed with the GelDoc imaging system (BioRad) using Quantity One software (Bio-Rad). Each experiment was repeated three times.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RNA was extracted from cultured keratinocytes with the TRIzol reagent (Invitrogen). RT-PCR was performed using RNA-PCR kit version 3.0 (Takara, Otsu, Japan). Brief complementary DNA amplification conditions were as follows. Cycles of denaturing at 94 o C for 30 seconds, annealing at 60 o C for 30 seconds and extension at 72 o C for 90 seconds were repeated 35 times with a final elongation step at 72 o C for 5 minutes. PCR products were electrophoresed in 4% Nusieve 3:1 agarose gel (FMC, Rockland, ME, USA) and analyzed quantitatively with the GelDoc imaging system (BioRad). We employed β-actin as a control. Primers used were as follows: DSG1, sense 5'-cttcaacgactgttaggtatgt-3', antisense 5'-gcaagttctttgaagattatcatc-3'; DSC1, sense 5'-taaagcagcgagctcacaaa-3', antisense 5'-ctgcatccactgcaacaact-3'; CDSN, sense 5'-atgatggcactgctgctg-3', antisense 5'-aaggtgccaatgctcttagc-3'; KLK5, sense 5'-gccacactgcaggaagaaa-3', antisense 5'-ggatttgaccccctggaa-3'; KLK7, sense 5'-gcatccccgactccaagaa-3', antisense 5'-cagggtacctctgcacaccaa-3'; β-actin, sense 5'-atggatgatgatatcgccgcg-3', antisense 5'-atgtcgtcccagttggtgacgat-3'. Each experiment was repeated three times.
Statistics
When comparisons were made between two groups, statistical significance was determined using the Student's t-test. When comparisons were made between multiple groups, statistical significance was determined using ANOVA analysis.
RESULTS
Effects of all-trans-retinol on the ultrastructure of the stratum corneum
Compared to the ethanol-treated epidermis, the stratum corneum was considerably disrupted by treatment with 2% all-trans-retinol in ethanol for 5 days. As illustrated in Fig. 1B , the corneocytes were widely separated and many of them were removed from the upper stratum corneum, resulting in a thinning of the stratum corneum layer in retinol-applied skin compared to vehicle-applied skin. Intercellular edema and degenerated corneodesmosomes were more pronounced in retinol-applied skin compared to vehicle-applied skin (Fig. 1C, B) .
RA downregulated DSG1 and DSC1 mRNA expression, but not CDSN mRNA expression in keratinocytes
Treatment of keratinocytes with RA (10 −6 M or 10 −7 M) for 24 hours resulted in a statistically significant decrease in DSG1 and DSC1 mRNA levels in keratinocytes under low-calcium (0.06 mM Ca
2+
) and high-calcium (1.5 mM Ca 2+ ) conditions. In contrast to DSG1 and DSC1, no effect on the transcriptional level of CDSN was observed (Fig.  2D) . Moreover, RA (10 −6 M or 10 −7 M) increased the CDSN mRNA levels in keratinocytes cultured under high-calcium conditions (Fig. 2D) .
RA downregulated DSG1 and DSC1 protein expression in keratinocytes
To determine whether RA could regulate the protein levels of DSG1 and DSC1 in addition to regulating transcription, DSG1 and DSC1 protein levels were assessed by western blotting in RA-treated keratinocytes. Western blot analysis showed that the DSG1 protein significantly decreased in keratinocytes cultured with RA (10 −6 M or 10 −7 M) for 24 hours in both low-and highcalcium media. Quantitative results showed that 10 −6 M or 10 −7 M RA decreased DSG1 protein expression by about 90% in keratinocytes cultured in low-calcium media. The addition of 10 −6 M RA and 10 −7 M RA to cultured keratinocytes in high-calcium media for 24 hours also resulted in decreased levels of DSG1 protein by 55% and 58%, respectively (Fig. 3A, B) . The protein expression of DSC1 significantly decreased by about 80% and 87% in keratinocytes treated with RA (10 −6 M or 10 −7 M) for 24 hours in low-calcium media, respectively. In high-calcium media, 10 Electron microscopic findings in the stratum corneum of hairless mouse skin treated with all-trans retinol. Increased corneocyte detachment and consequent thinning of the stratum corneum is clearly apparent in the all-trans retinol-treated skin (B, ×20,000) compared to the vehicle-applied skin (A, ×20,000). Degradation of the corneodesmosomes was also prominently seen in the all-trans retinol-treated skin (D, ×30,000) compared to the vehicle-applied skin (C, ×30,000). levels of DSG1 by 80% and 72%, respectively (Fig. 3A, C) .
RA did not affect the mRNA and protein expression levels of two serine proteases in the kallikrein family (KLK5 and KLK7) in keratinocytes
To verify that the inhibitory effect of RA on the expression of two corneodesmosomal components, DSG1 and DSC1, was due to the activation of the two serine proteases in the kallikrein family (KLK5 and KLK7), the mRNA and protein levels of the two serine proteases were assessed in RA-treated keratinocytes by RT-PCR and western blotting, respectively. RT-PCR showed that there was no statistically significant difference in KLK5 and KLK7 mRNA expression in keratinocytes treated with RA (10 −6 M or 10 −7 M) for 24 hours compared to untreated keratinocytes, under both low-and high-calcium conditions (Fig. 4) . Western blot analysis also showed no significant difference in protein levels of KLK5 and KLK7 in cultured keratinocytes treated with RA (10 −6 M or 10 −7 M) for 24 hours in low-calcium (0.06 mM Ca
2＋
) media compared to untreated keratinocytes. In high-calcium media (1.5 mM Ca 2＋ ), KLK5 protein levels in keratinocytes dose-dependently decreased by RA 
DISCUSSION
Retinol treatment on the skin of hairless mice showed increased detachment of corneocytes and degeneration of the corneodesmosomes, which was clearly apparent on electron microscopy images and consistent with the clinical findings of scaling or peeling. To elucidate the underlying mechanisms for this retinoid-induced degeneration of the corneodesmosomes, we investigated the effect of RA on the expression of the three major components of corneodesmosomes in cultured keratinocytes with different calcium concentrations. By using RT-PCR, we found that 10 −6 M and 10 −7 M RA treatment significantly decreased mRNA levels of DSG1 and DSC1 in keratinocytes, as compared to the untreated control. RA also reduced DSG1 and DSC1 protein expression by more than 50%. These results are in agreement with a previous study which showed that the transcription levels of DSG1 and DSC1 were dosedependently decreased by retinoic acid treatment in gingival epithelial cells 16 . Another in vivo study also demonstrated that 0.025% topical RA treatment reduced DSC1 expression, as compared to a non-specific irritant, sodium dodecyl sulphate, in human epidermis 6 .
It has been demonstrated that factors with a role in regulating epidermal differentiation may modulate the expression of desmosomal cadherins 17, 18 . For example, calcium and protein kinase C regulate the mRNA expression of DSG1 and DSG3 in cultured human keratinocytes 17 . The Rho-activated kinase signaling pathway, which is implicated in keratinocyte differentiation, has also been shown to upregulate genes for desmosomal cadherins 18 . Since retinoid is well-known for modulating growth and differentiation of the epidermis, we may expect that retinoid regulates the expression of desmosomal cadherins. There have been many studies which suggest that retinoid-induced skin fragility could partly result from the alteration or disruption of epidermal desmosomes 7, 16, [19] [20] [21] [22] . An electron microscopy study showed that systemic retinoid can cause skin fragility through a decreased number of tonofilaments and desmosomes in the epidermis 7 . We previously reported that RA induced loosening of the cell-to-cell contact of cultured keratinocytes and decreased the production of desmosomal proteins using immunohistochemistry and immunoblot analyses 19 . In previous in vitro studies, the RA-induced reduction of desmosomal cadherin expression was reported in cultured embryonic chick skin 20 and in a human keratinocyte cell line (HaCaT cells) 21 . An in vivo study using immunohistochemistry and western blot analysis showed that while some desmosomal components including desmoplakin, DSG1, plakophilin 1, and DSC3 were reduced equally by topical retinoids or another irritants like sodium lauryl sulphate, DSC1 and perhaps DSC2 were specifically reduced in retinoid-treated skin compared to SDS-treated skin 22 . Retinoic acid also disintegrated desmosomes by depriving cells of DSG1, DSC1, keratin 13, and keratin 14 in stratified oral keratinocytes 16 . Our results support these previous findings by clearly showing that RA is able to downregulate the transcription and protein expression of DSG1 and DSC1 in vitro. However, RA did not affect the transcription levels of CDSN in keratinocytes under low-calcium media. Moreover, CDSN mRNA expression was increased by RA treatment in high-calcium media. This result was not consistent with a previous study using a cDNA macro-array, showing that RA (1μM), 9-cis retinoic acid (1μM), or all-trans-retinol (10μM) significantly decreased the gene expression of some components of desmosomes, including DSG1, DSC1, DSC3, and CDSN, in reconstituted human epidermis 23 . The cause of these different effects of RA on CDSN expression in cultured human keratinocytes and reconstituted human epidermis remains unknown, but it may be partially explained by the different effects of RA on cellular proliferation and differentiation depending on the state of keratinocytes. It may also be possible that CDSN expression is induced by RA, thus compensating for the loss of DSC1 and DSG1. Another possible explanation is that the different effects of RA on the expression of these corneodesmosomal components may stem from the different origins between desmosomal cadherins and CDSN. Whereas two desmosomal cadherins, DSG1 and DSC1, begin to be expressed in the suprabasal layers of the epidermis and become concentrated in the upper epidermis, CDSN is synthesized in the upper spinous and granular layer and secreted via lamellar bodies 24 . The increased lamellar body secretion following permeability barrier impairment by retinoid may account for the increased CDSN expression by RA. In spite of the normal or increased CDSN at transcription levels, RA-induced reduction of DSG1 and DSC1 resulted in a marked alteration of corneodesmosomal structure in our study. These findings indicate that RA-induced reduction of DSG1 and DSC1, but not CDSN, is sufficient to cause the degradation of corneodesmosomes, thereby inducing excessive scaling and desquamation, which is commonly found in retinoid dermatitis. Desmosomal cadherins belong to the cadherin superfamily of calcium-dependent cell-cell adhesion molecules 25 . Four DSG (DSG 1-4) and three DSC (DSC 1-3)
have been identified in the epidermis in a differentiationspecific manner 26 . DSG3 and DSC3 are primarily found in the basal layer, whereas DSG1 and DSC1 are found in the more differentiated upper layers 27 . Calcium has been implicated in the formation, assembly, and stability of desmosomes 25 . However, in our study, a similar reduction in DSG1 or DSC1 expression was observed in RA-treated keratinocytes under both low-and high-calcium media. These findings may suggest that although extracellular calcium could modulate the expression of desmosomes, it could not affect the ability of RA to downregulate desmosomal cadherins. We also demonstrated that KLK5 and KLK7 expression in keratinocytes was not influenced by RA, both under lowand high-calcium media. These findings imply that KLK5 and KLK7 may not have a role in retinoid-induced desquamation processes. Although further studies are needed to investigate the precise mechanism by which RA regulates the transcription and protein expression of corneodesmosomal components, the results presented here suggest that the significant decrease in DSG1 and DSC1 by RA can induce the degradation of corneodesmosomes within the SC independently of KLK5 and KLK7, and consequently decrease cohesiveness of the SC, thereby causing retinoidinduced desquamation.
